Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2005-2008

Cancer Causes and Control

Volumn 25, Issue 3, 2014, Pages 395-403

  Eichholzer, Monika ^a   Richard, Aline ^a   Nicastro, Holly L ^b   Platz, Elizabeth A ^c,d   Linseisen, Jakob ^e   Rohrmann, Sabine ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

C reactive protein; Cross sectional study; Mammalian lignans; White blood cell count

Indexed keywords

C REACTIVE PROTEIN; CREATININE; ENTERODIOL; ENTEROLACTONE; ISOFLAVONE DERIVATIVE; LIGNAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SMOKING; SOCIAL STATUS; UNITED STATES; URINE LEVEL;

4-BUTYROLACTONE; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LIGNANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; UNITED STATES;

EID: 84895547625     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0340-3     Document Type: Article

References (57)

1. Wu SH, Shu XO, Chow WH, Xiang YB, Zhang X, Li HL, Cai Q, Ji BT, Cai H, Rothman N, Gao YT, Zheng W, Yang G (2012) Soy food intake and circulating levels of inflammatory markers in Chinese women. J Acad Nutr Diet 112(7):996-1004. doi: 10.1016/j.jand.2012.04.001
2. Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, Mejean C, Latino-Martel P, Hercberg S, Galan P, Czernichow S (2013) Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. Am J Epidemiol 177(1):3-13. doi: 10.1093/aje/kws359
3. Kotani K, Sakane N (2012) White blood cells, neutrophils, and reactive oxygen metabolites among asymptomatic subjects. Int J Prev Med 3(6):428-431
4. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12):836-843. doi: 10.1056/NEJM200003233421202
5. Iida M, Ikeda F, Ninomiya T, Yonemoto K, Doi Y, Hata J, Matsumoto T, Kiyohara Y (2012) White blood cell count and risk of gastric cancer incidence in a general Japanese population: the Hisayama study. Am J Epidemiol 175(6):504-510. doi: 10.1093/aje/kwr345
6. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805-1812. doi: 10.1172/JCI18921
7. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24(33):5216-5222. doi: 10.1200/JCO.2006.07.1381
8. Saito K, Kihara K (2011) C-reactive protein as a biomarker for urological cancers. Nat Rev Urol 8(12):659-666. doi: 10.1038/nrurol.2011.145
9. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK (2003) Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 138(11):891-897
10. Wener MH, Daum PR, McQuillan GM (2000) The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27(10):2351-2359
11. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282(22):2131-2135
12. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357(9258):763-767. doi: 10.1016/S0140-6736(00)04170-2
13. Yu Z, Ye X, Wang J, Qi Q, Franco OH, Rennie KL, Pan A, Li H, Liu Y, Hu FB, Lin X (2009) Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation 119(23):2969-2977. doi: 10.1161/CIRCULATIONAHA.108.833574
14. Nanri H, Nakamura K, Hara M, Higaki Y, Imaizumi T, Taguchi N, Sakamoto T, Horita M, Shinchi K, Tanaka K (2011) Association between dietary pattern and serum C-reactive protein in Japanese men and women. J Epidemiol 21(2):122-131
15. Zalokar JB, Richard JL, Claude JR (1981) Leukocyte count, smoking, and myocardial infarction. N Engl J Med 304(8):465-468. doi: 10.1056/ NEJM198102193040806
16. Dixon JB, O'Brien PE (2006) Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg 16(3):251-257. doi: 10.1381/096089206776116453
17. Aminzadeh Z, Parsa E (2011) Relationship between age and peripheral white blood cell count in patients with sepsis. Int J Prev Med 2(4):238-242
18. Pitsavos C, Chrysohoou C, Panagiotakos DB, Skoumas J, Zeimbekis A, Kokkinos P, Stefanadis C, Toutouzas PK (2003) Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study). Am J Cardiol 91(3):368-370
19. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288(8):980-987
20. Yoneyama S, Miura K, Sasaki S, Yoshita K, Morikawa Y, Ishizaki M, Kido T, Naruse Y, Nakagawa H (2007) Dietary intake of fatty acids and serum C-reactive protein in Japanese. J Epidemiol 17(3):86-92
21. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ 3rd, Li W, Pagoto SL, Hafner AR, Ockene IS (2006) Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 83(4):760-766
22. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC (2006) Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 84(6):1489-1497
23. Zampelas A, Panagiotakos DB, Pitsavos C, Das UN, Chrysohoou C, Skoumas Y, Stefanadis C (2005) Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol 46(1):120-124. doi: 10.1016/j.jacc.2005.03.048
24. Yang M, Chung SJ, Floegel A, Song WO, Koo SI, Chun OK (2013) Dietary antioxidant capacity is associated with improved serum antioxidant status and decreased serum C-reactive protein and plasma homocysteine concentrations. Eur J Nutr. doi: 10.1007/s00394-012-0491-5
25. Chun OK, Chung SJ, Claycombe KJ, Song WO (2008) Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr 138(4):753-760
26. Yang M, Chung SJ, Floegel A, Song WO, Koo SI, Chun OK (2013) Dietary antioxidant capacity is associated with improved serum antioxidant status and decreased serum C-reactive protein and plasma homocysteine concentrations. Eur J Nutr 52(8):1901-1911. doi: 10.1007/s00394-012-0491-5
27. Humfrey CD (1998) Phytoestrogens and human health effects: weighing up the current evidence. Nat Toxins 6(2):51-59. doi: 10.1002/(SICI)1522- 7189(199804)6:2<51:AID-NT11>3.0.CO;2-9
28. Patisaul HB, Jefferson W (2010) The pros and cons of phytoestrogens. Front Neuroendocrinol 31(4):400-419. doi: 10.1016/j.yfrne.2010.03.003
29. Branca F, Lorenzetti S (2005) Health effects of phytoestrogens. Forum Nutr 57:100-111
30. Hallund J, Tetens I, Bugel S, Tholstrup T, Bruun JM (2008) The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 18(7):497-502. doi: 10.1016/j.numecd.2007.05.007
31. Dodin S, Cunnane SC, Masse B, Lemay A, Jacques H, Asselin G, Tremblay-Mercier J, Marc I, Lamarche B, Legare F, Forest JC (2008) Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 24(1):23-30. doi: 10.1016/j.nut.2007.09.003
32. Pan A, Demark-Wahnefried W, Ye X, Yu Z, Li H, Qi Q, Sun J, Chen Y, Chen X, Liu Y, Lin X (2009) Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. Br J Nutr 101(8):1145-1149. doi: 10.1017/S0007114508061527
33. Lampe JW, Atkinson C, Hullar MA (2006) Assessing exposure to lignans and their metabolites in humans. J AOAC Int 89(4):1174-1181
34. Nicastro HL, Mondul AM, Rohrmann S, Platz EA (2013) Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008. Cancer Causes Control 24(6):1185-1196. doi: 10.1007/s10552-013-0198-9
35. Mondul AM, Selvin E, De Marzo AM, Freedland SJ, Platz EA (2010) Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004. Cancer Causes Control 21(5):671-678. doi: 10.1007/s10552-009-9494-9
36. Johnson CL, Paulose-Ram R, Ogden C (2013) National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital Health Stat 2(161):1-16
37. Penalvo JL, Lopez-Romero P (2012) Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults. J Nutr 142(4):751-756. doi: 10.3945/jn.111.150516
38. Barnes S, Coward L, Kirk M, Sfakianos J (1998) HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med 217(3):254-262
39. National Center for Health Statistics (2004) National Health and Nutrition Examination Survey. 2001-2002 Data documentation, codebook, and frequencies
40. Valentin-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB (2005) Urinary phytoestrogen concentrations in the U.S. population (1999-2000). J Expo Anal Environ Epidemiol 15(6):509-523. doi: 10.1038/sj.jea.7500429
41. Rybak ME, Sternberg MR, Pfeiffer CM (2013) Sociodemographic and lifestyle variables are compound- and class-specific correlates of urine phytoestrogen concentrations in the U.S. population. J Nutr 143(6):986S-994S. doi: 10.3945/jn.112.172981
42. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld B, Pasternak RC, Chae CU (2008) Ethnic differences in C-reactive protein concentrations. Clin Chem 54(6):1027-1037. doi: 10.1373/clinchem.2007.098996
43. Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, Tybjaerg-Hansen A, Smith GD (2011) C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 35(2):300-308. doi: 10.1038/ijo.2010.137
44. Kurzer MS (2003) Phytoestrogen supplement use by women. J Nutr 133(6):1983S-1986S
45. Davison S, Davis SR (2003) New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 88(6):2470-2478
46. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE (1999) Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100(7):713-716
47. Frohlich M, Sund M, Lowel H, Imhof A, Hoffmeister A, Koenig W (2003) Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J 24(14):1365-1372
48. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM (2006) Socioeconomic status and C-reactive protein levels in the US population: nHANES IV. Brain Behav Immun 20(5):498-504. doi: 10.1016/j.bbi.2005.10.003
49. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327-334
50. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Metelli MR, Giovannini L, Tetta C, Palla R (2001) C reactive protein in patients with chronic renal diseases. Ren Fail 23(3-4):551-562
51. Hage FG (2013) C-reactive protein and hypertension. J Hum Hypertens. doi: 10.1038/jhh.2013.111
52. Adlercreutz H (2007) Lignans and human health. Crit Rev Clin Lab Sci 44(5-6):483-525. doi: 10.1080/10408360701612942
53. Wang CS, Sun CF (2009) C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. Chang Gung Med J 32(5):471-482
54. Valentin-Blasini L, Blount BC, Caudill SP, Needham LL (2003) Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13(4):276-282. doi: 10.1038/sj.jea.7500278
55. Adolphe JL, Whiting SJ, Juurlink BH, Thorpe LU, Alcorn J (2010) Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br J Nutr 103(7):929-938. doi: 10.1017/S0007114509992753
56. van der Schouw YT, Sampson L, Willett WC, Rimm EB (2005) The usual intake of lignans but not that of isoflavones may be related to cardiovascular risk factors in U.S. men. J Nutr 135(2):260-266
57. Gaskins AJ, Wilchesky M, Mumford SL, Whitcomb BW, Browne RW, Wactawski-Wende J, Perkins NJ, Schisterman EF (2012) Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol 175(5):423-431. doi: 10.1093/aje/kwr343